NATURE BIOTECHNOLOGY
Scope & Guideline
Advancing the Future of Biotechnology
Introduction
Aims and Scopes
- Genome Editing and Engineering:
A central theme in the journal is the exploration and advancement of genome editing technologies, particularly CRISPR and its derivatives. This includes the development of novel editing systems that enhance specificity and reduce off-target effects. - Synthetic Biology:
Nature Biotechnology publishes studies on synthetic biology, which involves designing and constructing new biological parts, devices, and systems. This encompasses the engineering of microbes for applications in medicine, agriculture, and environmental sustainability. - Biotherapeutics and Drug Development:
The journal frequently features research on the development of biotherapeutics, including monoclonal antibodies, CAR-T therapies, and RNA-based therapeutics. This area focuses on the translation of basic research into clinical applications. - Bioinformatics and Computational Biology:
Computational approaches to analyzing biological data are a major focus, with studies leveraging machine learning, deep learning, and other computational tools to interpret complex biological datasets. - Microbiome Research:
Research on the microbiome and its implications for health and disease is increasingly prominent, reflecting a growing interest in understanding host-microbe interactions and their therapeutic potential. - Regenerative Medicine and Stem Cell Technology:
The journal covers advancements in regenerative medicine, including the use of stem cells for tissue engineering and the development of new therapies for degenerative diseases.
Trending and Emerging
- Advanced Genome Editing Techniques:
Newly developed genome editing tools, such as prime editing and base editing, are gaining traction. These methods promise greater precision and fewer off-target effects, driving interest in their applications across various fields. - Integration of AI in Biotechnology:
The application of artificial intelligence and machine learning in biotechnology is rapidly expanding. Researchers are leveraging these technologies for predictive modeling, data analysis, and optimizing biotechnological processes. - Personalized Medicine:
Research focused on personalized medicine, particularly in the context of cancer and rare diseases, is on the rise. This trend is driven by advancements in genomics and an increasing emphasis on tailored therapeutic approaches. - Sustainability and Environmental Biotechnology:
There is an emerging focus on biotechnological solutions aimed at addressing environmental challenges, such as bioremediation and sustainable agricultural practices, reflecting a broader societal push towards sustainability. - Cell and Gene Therapies:
The field of cell and gene therapies is rapidly advancing, with increasing numbers of studies exploring novel therapies and delivery methods, particularly in the context of genetic disorders and cancer treatment.
Declining or Waning
- Traditional Drug Discovery Methods:
As biotechnology evolves, traditional methods of drug discovery, which rely heavily on high-throughput screening of small molecules, are becoming less prominent. The focus has shifted towards more innovative approaches, such as utilizing AI and machine learning for drug development. - Plant Biotechnology:
Although still relevant, the frequency of publications specifically focused on plant biotechnology has decreased as the field expands into more integrated approaches combining multiple disciplines such as synthetic biology and gene editing. - Animal Models in Drug Testing:
There appears to be a decline in studies centered around traditional animal models for drug testing, as researchers increasingly explore alternative methods, including organoids and in vitro systems that better mimic human physiology. - Single-Cell Genomics:
While single-cell genomics remains important, there is a noticeable shift towards more integrative approaches that combine single-cell data with spatial transcriptomics and proteomics, indicating a transition away from isolated single-cell studies.
Similar Journals
AIMS Bioengineering
Unlocking Potential in Biomaterials and BeyondAIMS Bioengineering, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing knowledge in the interdisciplinary field of bioengineering. With the ISSN 2375-1495, this journal has been providing a platform for the rapid dissemination of high-quality research since its establishment in 2014. AIMS Bioengineering covers a wide range of topics, including but not limited to, biomaterials, computational biology, and bioinformatics, making it an essential resource for researchers, professionals, and students alike. Although the H-index and specific category quartiles are not currently available, the journal's commitment to open access ensures that cutting-edge findings are accessible to a global audience, fostering collaboration and innovation in bioengineering. With its rigorous peer-review process and dedication to scholarly excellence, AIMS Bioengineering continues to play a pivotal role in shaping the future of the bioengineering landscape.
GEN Biotechnology
Unleashing Potential: Where Research Meets ApplicationGEN Biotechnology, published by MARY ANN LIEBERT, INC, is a pivotal journal dedicated to advancing the field of biotechnology through the dissemination of high-quality research. With its ISSN 2768-1572 and E-ISSN 2768-1556, this journal seeks to bridge the gap between fundamental biotechnology research and its practical applications across various industries. As a leading publication in the life sciences arena, it emphasizes innovative studies in areas such as genetic engineering, molecular biology, bioinformatics, and synthetic biology. Although currently not open access, GEN Biotechnology offers a platform for researchers, professionals, and students to delve into cutting-edge findings that significantly impact health, agriculture, and environmental sustainability. Its commitment to excellence is underscored by its strive for high visibility within the global research community.
EuroBiotech Journal
Bridging Science and Innovation for Global ImpactEuroBiotech Journal, published by SCIENDO, is an essential open-access platform for researchers and professionals in the fields of biomedical engineering, biotechnology, food science, genetics, molecular biology, and molecular medicine. Since its establishment in 2017, the journal has aimed to disseminate high-quality, peer-reviewed research that fosters innovation and collaboration within the European biotechnological landscape and beyond. With its target audience comprising academic scholars, industry practitioners, and students, EuroBiotech Journal has successfully carved a niche, achieving notable Scopus ranks and quartiles, such as Q3 in Biotechnology and Food Science. Based in Warsaw, Poland, the journal welcomes manuscripts that contribute to the vast array of current topics, addressing pressing challenges and discovering solutions pertinent to biotechnology and its applications. As you explore the latest advancements published in this journal, you will find a rich source of knowledge that promotes a deeper understanding of the dynamic and evolving field of biotechnological research.
Biotechnology and Genetic Engineering Reviews
Reviewing Breakthroughs in Genetic Engineering and Biotech.Biotechnology and Genetic Engineering Reviews is a prominent journal published by Taylor & Francis Ltd, specializing in the rapidly evolving fields of biotechnology and genetic engineering. Since its inception in 1984, this journal has served as a critical platform for researchers and professionals to disseminate groundbreaking scientific findings, review methodologies, and discuss emerging trends within the domain. With a substantial track record of convergence in its publication history from various years, it currently holds Q2 rankings in both Bioengineering and Biotechnology, alongside a Q3 ranking in Molecular Biology for 2023. Its dedication to quality research is reflected in its Scopus rankings, which position the journal favorably within the competitive landscape of biochemistry and molecular biology. Although it is not an open-access journal, Biotechnology and Genetic Engineering Reviews remains committed to providing accessible insights to the global scientific community, making it an invaluable resource for students, academics, and industry professionals keen on advancing their knowledge in these crucial fields.
MOLECULAR BIOTECHNOLOGY
Fostering Innovation at the Intersection of Science and TechnologyMOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.
Regenerative Engineering and Translational Medicine
Driving Innovation at the Intersection of Science and HealthRegenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.
PROTEIN EXPRESSION AND PURIFICATION
Pioneering Insights in Biochemistry and Molecular BiologyPROTEIN EXPRESSION AND PURIFICATION, published by Academic Press Inc. Elsevier Science, is a premier journal in the field of biotechnology. With its ISSN 1046-5928 and E-ISSN 1096-0279, the journal has been a vital source of knowledge since its inception in 1990 and continues to provide high-quality research up to 2025. Though categorized in the third quartile (Q3) for 2023 within its scope of biochemistry, genetics, and molecular biology, it serves as a valuable platform for scientists and researchers focusing on the latest advancements in protein expression methodologies and purification techniques. The journal enjoys a respectable Scopus rank of 177 out of 311 in its category, representing a 43rd percentile position that underscores its impact in the research community. While not an Open Access journal, it offers a wealth of insights that can significantly enhance one's understanding of protein biochemistry, making it a must-read for professionals and students alike engaged in this dynamic field.
Bioengineering-Basel
Exploring the Future of BioengineeringBioengineering-Basel, an esteemed journal published by MDPI, stands at the forefront of innovation in the field of bioengineering since its inception in 2014. With an E-ISSN of 2306-5354, this fully Open Access journal based in Switzerland provides a platform for researchers and professionals to disseminate cutting-edge findings across various aspects of bioengineering, including biomaterials, tissue engineering, and biopharmaceuticals. The journal has been recognized with a Q3 ranking in the 2023 Bioengineering category, reflecting its commitment to quality and relevance. By facilitating widespread accessibility to academic knowledge, Bioengineering-Basel aims to foster collaboration and stimulate thought leadership within the global research community, making it an indispensable resource for students, scholars, and industry practitioners alike.
JOURNAL OF BIOTECHNOLOGY
Exploring the intersection of microbiology and innovation.JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.
Journal of Biological Engineering
Connecting Scholars to Drive Biological InnovationJournal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.